Coreg® Tablets 12.5 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

CompletedNCT00648622

Mylan Pharmaceuticals IncHealthy

Start: 2004-04-30End: 2004-04-30Updated: 2024-04-24

Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

CompletedNCT00650416

Mylan Pharmaceuticals IncHealthy

Start: 2004-03-31End: 2004-04-30Updated: 2024-04-24